STAT3 and prostate cancer: Furthermore, it has also been found that the STAT3 signaling contributes to oncolytic NDV-induced ICD in melanoma cells (Shao et al., 2019) and that targeting STAT3 enhances NDV-induced ICD in prostate cancer cells (Wang et al., 2020b).